MDCX Medicus Pharma Ltd. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$0.27
Price · May 20, 2026
Fundamentals as of May 14, 2026
52W Range
$0–$9
0% of range
Analyst Rating
BUY
10 analysts
Price Target
$6
+2274% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

MDCX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.27
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $9

MDCX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MDCX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MDCX
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MDCX
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MDCX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MDCX
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MDCX
Peer Median

MDCX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-05-15
Median target $7.50 +2639.2%
Mean target $6.50 +2274.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.23%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.31 $-0.20 -0.11%
Dec. 31, 2025 $-0.83 $-0.16 -0.67%
Sept. 30, 2025 $-0.65 $-0.30 -0.35%
June 30, 2025 $-0.42 $-0.26 -0.16%
March 31, 2025 $-0.42 $-0.24 -0.18%
Dec. 31, 2024 $-0.18 $-0.30 0.12%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MDCX — — — — — —
PMN $15M -0.3 — — 4840.3% —
XENE $3.59B -10.3 — -4612.1% -56.9% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.